Table 1 Summary of patients’ demographics, underlying diseases, clinical data, blood results, and hemodialysis details
From: Mallory-Weiss syndrome in four hemodialysis patients: a case study
Patient | P1 | P2 | P3 | P4 |
|---|---|---|---|---|
Sex | Male | Female | Female | Male |
Age (years) | 31 | 65 | 69 | 61 |
Underlying disease | IgA nephropathy | Chronic glomerulonephritis | Diabetic nephropathy | Diabetic nephropathy |
Comorbid disease | No | No | Systemic scleroderma coronary heart disease | coronary heart disease |
Digestive system diseases | No | Chronic superficial gastritis, constipation | Constipation | Constipation |
Long-term oral drug administration | No | No | Glucocorticoids | Aspirin |
Frequency of HD | 12Â h/week | 8Â h/week | 10Â h/week | 12Â h/week |
Frequency of HDF | 8Â h/month | No | 4Â h/month | 4Â h/month |
Years on HD | 3 | 2 | 3 | 1 |
Anticoagulants and doses used in dialysis | Low-molecular-weight heparin 3000 U/time | Low-molecular-weight heparin 1000 U/time | Low-molecular-weight heparin 3500 U/time | Low-molecular-weight heparin 5000 U/time |
Vascular access | Arterio-venous fistula | Right femoral vein catheterization (heparin saline 1:1 tube sealing) | Semi-permanent catheterization of right internal jugular vein (sealed with heparin only) | Arterio-venous fistula |
Accompanied by cardiac insufficiency | No | No | Yes | Yes |
Accompanied by thrombocytopenia | No (123*1012/L) | No (256*1012/L) | Yes (78*1012/L) | No (201*1012/L) |
With coagulation dysfunction | No (PT 13.1Â s) | Yes (PT 19.3Â s) | No (PT 13.8Â s) | Yes (PT 18.1Â s) |
Serum creatinine level before dialysis (μmol/L)a | 1000 | 800 | 500 | 800 |
BUN (mmol/L) | 15.4 | 16.78 | 17.2 | 15.3 |
Pre-onset Hbb levels (g/L) | 115 | 75 | 107 | 107 |
Hb level at onset (g/L) | 87 | 43 | 85 | 99 |
Kt/V | 1.44 | 1.25 | 1.13 | 1.32 |